Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech's Ion AmpliSeq Exome CSP Program Adds 12 Members

NEW YORK (GenomeWeb News) – Twelve organizations in the US, Europe, and Asia Pacific have joined Life Technologies' Ion AmpliSeq Exome Certified Service Provider program, bringing total membership to more than 30, Life Tech said today.

The new members are US-based Kashi Clinical Laboratories, RUCDR Infinite Biologics, WuXi AppTec, Molecular Resource Center, and Research and Testing Laboratory; Europe's Fasteris, Eurofins MWG Operon, NIMGenetics, Genomax, and Cellcall; Australia's Lotterywest State Biomedical Facility; and South Korea's DNA Link.

In addition, molecular testing company Cynvenio Biosystems has joined the Ion Certified Service Provider program, of which the Ion AmpliSeq Exome CSP is a part.

In order to be a CSP for AmpliSeq exome sequencing, service providers must demonstrate that they can generate at least 30 million reads per exome using 50 nanograms of starting DNA, cover 88 percent to 90 percent of the exome at 20x, and do the sequencing for an all-in reagents cost of $400. Additionally, providers must be able to sequence two exomes in one two-hour run with a total turnaround time of two days.

"The popularity of the Ion AmpliSeq Exome Certified Service Provider program has grown rapidly, reflecting significant underlying demand for fast, easy-to-use Ion AmpliSeq Exome sequencing," Maneesh Jain, vice president of marketing and business development at Ion Torrent, said in a statement.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.